| Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial A Pisani, E Riccio, M Sabbatini, M Andreucci, A Del Rio, B Visciano Nephrology dialysis transplantation 30 (4), 645-652, 2015 | 172 | 2015 |
| Role of reactive oxygen species in pathogenesis of radiocontrast‐induced nephropathy A Pisani, E Riccio, M Andreucci, T Faga, M Ashour, A Di Nuzzi, A Mancini, ... BioMed research international 2013 (1), 868321, 2013 | 135 | 2013 |
| Diagnostic, predictive, prognostic, and therapeutic molecular biomarkers in third millennium: a breakthrough in gastric cancer N Carlomagno, P Incollingo, V Tammaro, G Peluso, N Rupealta, ... BioMed research international 2017 (1), 7869802, 2017 | 123 | 2017 |
| Mutations in the GLA gene and LysoGb3: is it really Anderson-Fabry disease? G Duro, C Zizzo, G Cammarata, A Burlina, A Burlina, G Polo, S Scalia, ... International journal of molecular sciences 19 (12), 3726, 2018 | 99 | 2018 |
| The kidney in Fabry's disease A Pisani, B Visciano, M Imbriaco, A Di Nuzzi, A Mancini, C Marchetiello, ... Clinical genetics 86 (4), 301-309, 2014 | 80 | 2014 |
| Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury A Pisani, M Sabbatini, E Riccio, R Rossano, M Andreucci, C Capasso, ... Clinical and Experimental Nephrology 18, 424-431, 2014 | 75 | 2014 |
| The potential use of biomarkers in predicting contrast-induced acute kidney injury M Andreucci, T Faga, E Riccio, M Sabbatini, A Pisani, A Michael International journal of nephrology and renovascular disease, 205-221, 2016 | 74 | 2016 |
| Long-term effects of octreotide on liver volume in patients with polycystic kidney and liver disease A Pisani, M Sabbatini, M Imbriaco, E Riccio, N Rubis, A Prinster, A Perna, ... Clinical Gastroenterology and Hepatology 14 (7), 1022-1030. e4, 2016 | 69 | 2016 |
| Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): a randomized, double-blind, placebo-controlled, multicenter trial N Perico, P Ruggenenti, A Perna, A Caroli, M Trillini, S Sironi, A Pisani, ... PLoS medicine 16 (4), e1002777, 2019 | 65 | 2019 |
| C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial P Ruggenenti, E Daina, A Gennarini, C Carrara, S Gamba, M Noris, ... American Journal of Kidney Diseases 74 (2), 224-238, 2019 | 63 | 2019 |
| Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial E Riccio, M Sabbatini, D Bruzzese, I Capuano, S Migliaccio, M Andreucci, ... PLoS One 10 (3), e0118174, 2015 | 55 | 2015 |
| Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media A Michael, T Faga, A Pisani, E Riccio, P Bramanti, M Sabbatini, M Navarra, ... BioMed research international 2014 (1), 249810, 2014 | 55 | 2014 |
| Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data E Riccio, M Zanfardino, L Ferreri, C Santoro, S Cocozza, I Capuano, ... European Journal of Human Genetics 28 (12), 1662-1668, 2020 | 53 | 2020 |
| Effects of switching from agalsidase beta to agalsidase alfa in 10 patients with Anderson-Fabry disease A Pisani, L Spinelli, B Visciano, I Capuano, M Sabbatini, E Riccio, ... JIMD Reports–Case and Research Reports, 2012/6, 41-48, 2013 | 49 | 2013 |
| Current tissue molecular markers in colorectal cancer: a literature review G Peluso, P Incollingo, A Calogero, V Tammaro, N Rupealta, G Chiacchio, ... BioMed research international 2017 (1), 2605628, 2017 | 47 | 2017 |
| Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients? E Riccio, M Cataldi, M Minco, G Argentino, R Russo, S Brancaccio, ... PLoS One 9 (4), e95811, 2014 | 43 | 2014 |
| Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients R Esposito, M Galderisi, C Santoro, M Imbriaco, E Riccio, ... European Heart Journal-Cardiovascular Imaging 20 (4), 438-445, 2019 | 42 | 2019 |
| Therapeutic advances in ADPKD: the future awaits I Capuano, P Buonanno, E Riccio, M Amicone, A Pisani Journal of nephrology 35 (2), 397-415, 2022 | 41 | 2022 |
| Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a Cross-Sectional Observational Study B Guida, M Cataldi, E Riccio, L Grumetto, A Pota, S Borrelli, A Memoli, ... PLoS One 8 (8), e73558, 2013 | 41 | 2013 |
| Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: preliminary data G Servillo, M Vargas, A Pastore, A Procino, M Iannuzzi, A Capuano, ... BioMed research international 2013 (1), 108951, 2013 | 41 | 2013 |
Antonio PisaniCattedra di Nefrologia Università Federico II di NapoliEmail verificata su unina.it
